|Audit||Nominating and Governance||Compensation|
Hubert Birner Ph.D., M.B.A.
Chairman of the Board
Hubert Birner, Ph.D. has served as the Chairman of our board of directors since 2005 and a member of our board of directors since 2001. Dr. Birner joined the Munich office of TVM Capital, a venture capital firm and affiliate of Argos, as an investment manager in 2000 and currently serves as the Managing Partner of the firm. From 1998 to 2000, Dr. Birner served as head of European business development and director of marketing for Germany at Zeneca Agrochemicals, a biopharmaceutical company. Prior to joining Zeneca Agrochemicals, Dr. Birner served as a management consultant in McKinsey & Company's European healthcare and pharmaceutical practice. Dr. Birner currently serves on the board of directors of Proteon Therapeutics, Inc. and SpePharm Holdings BV. Dr. Birner previously served on the board of directors of Horizon Pharma, Inc., Bioxell SA, Evotec AG and Jerini AG. Dr. Birner received an M.B.A. from Harvard Business School and a doctorate in biochemistry from Ludwig-Maximilians University in Munich, Germany. His doctoral thesis was honored with the Hoffmann-La Roche prize for outstanding basic research in metabolic diseases.
Robert F. Carey
Robert Carey has been a member of the board of directors since September 2015. Mr. Carey is Executive Vice President and Chief Business officer at Horizon Pharma plc. From 2003 to 2014, Mr. Carey was Managing Director and head of healthcare investment banking at JMP Securities LLC. Prior to that, Mr. Carey held various senior positions at several investment banking firms, including Dresdner Kleinwort Wasserstein, Inc., Prudential Securities Incorporated, Vector Securities International, Inc., and Shearson Lehman Hutton Inc. He has served as an advisor on greater than $15 billion in financings, as well as numerous mergers and acquisitions. He is a member of the board of directors for Red Hen Corporation, Hawthorne Race Course, Inc., and Suburban Downs, Inc. He is also a former member of the board of directors for the Illinois Biotechnology Industry Organization (iBIO). Mr. Carey holds a BBA in accounting from the University of Notre Dame.